Literature DB >> 29452958

BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far.

Babita Sharma1, Raman Preet Kaur1, Sonali Raut1, Anjana Munshi2.   

Abstract

BRCA1 gene mutations account for about 25-28% of hereditary Breast Cancer as BRCA1 is included in the category of high penetrance genes. Except for few commonmutations, there is a heterogenous spectrum of BRCA1 mutations in various ethnic groups. 185AGdel and 5382ins Care the most common BRCA1 alterations (founder mutations) which have been identified in most of the population. This review has been compiled with an aim to consolidate the information on genetic variants reported in BRCA1 found in various ethnic groups, their functional implications if known; involvement of BRCA1 in various cellular pathways/processes and potential BRCA1 targeted therapies. The pathological variations of BRCA1 vary among different ethical groups. A systematic search in PubMed and Google scholar for the literature on BRCA1 gene was carried out to figure out structure and function of BRCA1 gene. BRCA1 is a large protein having 1863 amino acids with multiple functional domains and interacts with multiple proteins to carry out various crucial cellular processes. BRCA1 plays a major role in maintaining genome integrity, transcription regulation, chromatin remodeling, cell cycle checkpoint control, DNA damage repair, chromosomal segregation, and apoptosis. Studies investigating the phenotypic response of mutant BRCA1 protein and comparing it to wildtype BRCA1 protein are clinically important as they are involved in homologous recombination and other repair mechanisms. These studies may help in developing more targetted therapies, detecting novel interacting partners, identification of new signaling pathways that BRCA1 is a part of or downstream target genes that BRCA1 affects.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BRCA1; Breastcancer; DNA damage repair; Mutations

Mesh:

Substances:

Year:  2018        PMID: 29452958     DOI: 10.1016/j.currproblcancer.2018.01.001

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  7 in total

1.  Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.

Authors:  Zeinab Abbasi-Radmoghaddam; Siavash Riahi; Sajjad Gharaghani; Mohammad Mohammadi-Khanaposhtanai
Journal:  Mol Divers       Date:  2020-03-05       Impact factor: 2.943

2.  Germline Pathogenic Variants in Homologous Recombination and DNA Repair Genes in an Asian Cohort of Young-Onset Colorectal Cancer.

Authors:  Ming Ren Toh; Jian Bang Chiang; Siao Ting Chong; Sock Hoai Chan; Nur Diana Binte Ishak; Eliza Courtney; Wei Hao Lee; Syed Muhammad Fahmy Bin Syed Abdillah Al; John Carson Allen; Kiat Hon Lim; Sonia Davila; Patrick Tan; Weng Khong Lim; Iain Bee Huat Tan; Joanne Ngeow
Journal:  JNCI Cancer Spectr       Date:  2018-12-10

3.  ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.

Authors:  Jun Xu; Sek Man Su; Xin Zhang; Un In Chan; Ragini Adhav; Xiaodong Shu; Jianlin Liu; Jianjie Li; Lihua Mo; Yuqing Wang; Tingting An; Josh Haipeng Lei; Kai Miao; Chu-Xia Deng; Xiaoling Xu
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

4.  S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy.

Authors:  Jianjie Li; Xiaodong Shu; Jun Xu; Sek Man Su; Un In Chan; Lihua Mo; Jianlin Liu; Xin Zhang; Ragini Adhav; Qiang Chen; Yuqing Wang; Tingting An; Xu Zhang; Xueying Lyu; Xiaoling Li; Josh Haipeng Lei; Kai Miao; Heng Sun; Fuqiang Xing; Aiping Zhang; Chuxia Deng; Xiaoling Xu
Journal:  Nat Commun       Date:  2022-03-18       Impact factor: 14.919

5.  Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

Authors:  Alessandro Lavoro; Aurora Scalisi; Saverio Candido; Guido Nicola Zanghì; Roberta Rizzo; Giuseppe Gattuso; Giuseppe Caruso; Massimo Libra; Luca Falzone
Journal:  Int J Oncol       Date:  2022-04-06       Impact factor: 5.650

6.  Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.

Authors:  Meryem Ozgencil; Julian Barwell; Marc Tischkowitz; Louise Izatt; Ian Kesterton; Michael Simpson; Paul Sharpe; Paulo de Sepulveda; Edwige Voisset; Ellen Solomon
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

7.  A new bioinformatics tool to help assess the significance of BRCA1 variants.

Authors:  Isabelle Cusin; Daniel Teixeira; Monique Zahn-Zabal; Valentine Rech de Laval; Anne Gleizes; Valeria Viassolo; Pierre O Chappuis; Pierre Hutter; Amos Bairoch; Pascale Gaudet
Journal:  Hum Genomics       Date:  2018-07-11       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.